Advertisement
New Zealand markets close in 4 hours 5 minutes
  • NZX 50

    11,894.93
    +14.39 (+0.12%)
     
  • NZD/USD

    0.6184
    +0.0005 (+0.07%)
     
  • NZD/EUR

    0.5679
    +0.0006 (+0.11%)
     
  • ALL ORDS

    8,007.60
    +13.50 (+0.17%)
     
  • ASX 200

    7,753.90
    +16.80 (+0.22%)
     
  • OIL

    73.15
    -0.10 (-0.14%)
     
  • GOLD

    2,348.90
    +1.50 (+0.06%)
     
  • NASDAQ

    18,654.84
    +53.84 (+0.29%)
     
  • FTSE

    8,232.04
    -30.71 (-0.37%)
     
  • Dow Jones

    38,711.29
    +140.29 (+0.36%)
     
  • DAX

    18,405.64
    -202.56 (-1.09%)
     
  • Hang Seng

    18,444.11
    +41.11 (+0.22%)
     
  • NIKKEI 225

    38,402.73
    -434.73 (-1.12%)
     
  • NZD/JPY

    95.9290
    +0.2850 (+0.30%)
     

Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals.

While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics.

Why Investors Should Pay Attention to This Value Stock

Finding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, and Price/Cash Flow to highlight the most attractive and discounted stocks.

ADVERTISEMENT

Henry Schein (HSIC)

Melville, NY-headquartered Henry Schein Inc. is a leading distributor of health care products and services across the globe. The company serves office-based dental, medical and animal health practitioners, dental laboratories, government as well as institutional health care clinics and other alternate-care sites. Presently, Henry Schein operates in 33 countries.

HSIC is a Zacks Rank #3 (Hold) stock, with a Value Style Score of A and VGM Score of B. Shares are currently trading at a forward P/E of 14X for the current fiscal year compared to the Medical - Dental Supplies industry's P/E of 17.9X. Additionally, HSIC has a PEG Ratio of 1.8 and a Price/Cash Flow ratio of 10.7X. Value investors should also note HSIC's Price/Sales ratio of 0.7X.

Many value investors pay close attention to a company's earnings as well. For HSIC, one analyst revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.01 to $5.07 per share for 2024. Per share HSIC boasts an average earnings surprise of 2.6%.

HSIC should be on investors' short lists because of its impressive earnings and valuation fundamentals, a good Zacks Rank, and strong Value and VGM Style Scores.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Henry Schein, Inc. (HSIC) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research